How TRT Samples Work in 2026: Schedule III Rules, Free Trials & What's Actually Free

Two layers of federal law stack to restrict testosterone sampling. The Prescription Drug Marketing Act (PDMA, 1987, codified at 21 U.S.C. § 353(d)) restricts all pharmaceutical sampling to licensed prescribers, residents in training, and (in narrow circumstances) pharmacies. That's the same restriction that applies to GLP-1 medications, ED drugs, and everything else.

Testosterone has a second layer: Schedule III controlled-substance status under the Controlled Substances Act. The DEA imposes additional record-keeping, prescription-form, and dispensing requirements on Schedule III drugs. Combined, these rules mean:

• Manufacturers cannot ship samples directly to patients
• Patients cannot order samples online without a prescription
• Even prescriber-distributed samples must be tracked under DEA controlled-substance records
• Quantities of sample testosterone available to prescribers are smaller than for non-controlled drugs

Practical implication: if a website offers "free testosterone shipped to your door without a prescription," it is almost certainly either (a) a fraud, (b) an unregulated foreign pharmacy operating outside US law, or (c) a misrepresented promo for a legitimate telehealth subscription where the "free" is the first-month discount.

The major telehealth TRT platforms — Hims TRT, Hone Health, Maximus Tribe — all run new-patient promos that drop the first month from the $200-300 ongoing rate to $99 (sometimes lower with referral codes). For a patient who's never been on TRT, this is the most accessible "try the product" path in 2026.

What you actually get for $99 typically includes:

• Async clinical intake (BMI, symptoms, medical history, medications)
• Baseline labs (testosterone, estradiol, hematocrit, PSA, lipids — sometimes broader)
• Clinician review + prescription
• 30-day supply of testosterone cypionate (typically 1mL or 1.5mL of 200mg/mL)
• Injection supplies (syringes, needles, sharps container, alcohol pads)
• Shipping (discreet, expedited)
• Patient education materials + injection instructions

The economics work because TRT is a long-tenure subscription. Once a patient confirms the clinical benefit (usually within 4-8 weeks), they typically continue for years. Customer acquisition cost of $100-200 (the subsidized first month plus marketing spend) is justified by 24-month-plus average retention at $200-300/month.

Brand-name testosterone products run patient assistance programs that drop copay for commercially insured patients. The most-used:

• AbbVie AndroGel Patient Savings Program — Drops AndroGel copay to $30 or less for eligible commercial-insurance patients. Application at the AbbVie patient site; pharmacy applies the card at fill.
• Endo Aveed Patient Support — Aveed (testosterone undecanoate, 10-week injection) is one of the most expensive TRT formulations at retail. Endo's program reduces copay for eligible patients with covering insurance.
• Antares Xyosted Savings — Xyosted is a self-administered weekly testosterone enanthate auto-injector. Antares offers savings card support for commercially-insured patients.
• Endo Testopel Patient Support — Testopel (testosterone pellet) requires in-office insertion; Endo's program helps with insertion + medication cost for eligible patients.

Federal-plan enrollees — anyone with Medicare, Medicaid, VA, or Tricare coverage — cannot use these copay savings cards. The federal Anti-Kickback Statute prohibits manufacturer copay assistance for federal-program beneficiaries. This is the single most-misunderstood point about manufacturer savings cards.

For the 95%+ of TRT patients on generic cypionate or enanthate, savings cards don't apply — generics aren't typically supported by manufacturer copay programs. For those patients, cash-pay through Costco or another retail pharmacy with GoodRx is the cleanest path. Cypionate 10mL multi-dose vial cash-pay runs $30-60 at Costco; 30 weekly injections per vial means 3-month supply for the cost of a single AndroGel copay.

For uninsured low-income patients prescribed brand-name testosterone, manufacturer Patient Assistance Programs may provide free or deeply-discounted product. The major programs:

• myAbbVie Assist — AndroGel for income-qualified uninsured patients
• Endo Patient Foundation — Aveed, Testopel for eligible uninsured patients
• NeedyMeds + RxAssist — third-party clearinghouses listing all current PAPs by drug

PAP eligibility typically requires: (1) US residency, (2) household income below a threshold (often 400-500% of federal poverty level), (3) no insurance coverage for the medication, (4) prescriber willingness to enroll the patient in the program. The application process takes 2-6 weeks; once approved, medication is typically shipped quarterly.

For TRT specifically, PAPs are almost always for brand-name product. Generic cypionate is rarely covered by PAPs because the cash-pay price is already low ($30-60 at Costco). The practical PAP audience for TRT is a narrow slice: uninsured patients whose clinician has specifically prescribed brand-name AndroGel or Aveed for clinical reasons (gel for non-injectable delivery, Aveed for the 10-week dosing convenience).

For a patient with an existing TRT prescription, the cheapest legitimate cash-pay path is Costco pharmacy + GoodRx for generic testosterone cypionate. The math:

• 10mL multi-dose vial of cypionate 200mg/mL: $30-60 cash with GoodRx
• One vial = 2,000mg = 30+ weekly 60mg doses (or 10 weekly 200mg doses)
• Effective monthly cost: $10-20 for medication alone

The catches: (1) you need an active prescription, which requires a clinician relationship that includes appropriate baseline labs and ongoing monitoring — separate from the pharmacy fill, (2) you need to handle injection supplies yourself (syringes from Amazon or pharmacy), (3) you don't get the bundled lab interpretation and clinical support that a telehealth subscription includes.

For most patients, the math says: telehealth subscription ($99-199/month all-in) for the first 6-12 months until you're stable, then potentially graduate to cash-pay-pharmacy + independent lab monitoring once you're on a stable protocol. Specialty clinics (Defy, Marek) at $300-500/month are appropriate for patients with complex protocols where the clinical depth is worth the premium.